Ascendis Pharma A/S (ASND) Financials: Revenue & Earnings
$16.61B
Market Cap
—
P/E
—
Forward P/E
—
Score
ASND price $252.43 +2.88 +1.15%
ASND fair value $186.73. Price $252.43. Price is 35% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | 0.91 | — | 412.31M |
| 2026-08-13 | 3.29 | 1.71 | 387.48M | 376.75M |
| 2026-05-07 | 0.32 | 0.19 | 284.92M | 308.93M |
| 2026-02-11 | -0.64 | -0.06 | 344.84M | 292.26M |
| 2025-11-12 | -1.17 | -0.41 | 250.22M | 302.60M |
| 2025-08-07 | -0.93 | -1.42 | 186.09M | 233.12M |
| 2025-05-01 | -1.66 | -1.56 | 110.67M | 153.48M |
| 2025-02-12 | -0.68 | -1.20 | 180.09M | 125.42M |
| 2024-11-14 | -1.81 | -1.83 | 63.43M | 74.14M |
| 2024-09-03 | -2.05 | -1.54 | 38.71M | 37.58M |
| 2024-05-02 | -2.48 | -1.62 | 103.02M | 92.36M |
| 2024-02-07 | -1.66 | -2.19 | 151.44M | 111.12M |
| 2023-11-07 | -3.08 | -2.55 | 50.67M | 55.32M |
| 2023-09-05 | -2.35 | -2.68 | 55.40M | 43.53M |
| 2023-04-27 | -2.18 | -2.93 | 36.52M | 25.78M |
| 2023-02-16 | -3.96 | -2.74 | 24.66M | 22.05M |
| 2022-11-02 | -3.05 | -2.52 | 14.93M | 13.60M |
| 2022-08-10 | -1.50 | -2.19 | 6.44M | 6.01M |
| 2022-05-11 | -2.31 | -2.09 | 7.55M | 5.25M |
| 2022-03-02 | -2.06 | -2.57 | 5.55M | 3.38M |
| 2021-11-10 | -1.69 | -2.63 | 1.29M | 1.70M |
| 2021-08-25 | -3.01 | -2.75 | 1.21M | 1.30M |
| 2021-05-27 | -1.43 | -2.09 | 877.43K | 1.19M |
| 2021-03-10 | -3.15 | -1.84 | 656.11K | 2.07M |
| 2020-11-11 | -2.73 | -1.87 | 3.24M | 2.84M |
| 2020-08-27 | -2.34 | -1.71 | 1.62M | 1.24M |
| 2020-05-19 | -1.44 | -1.48 | 2.42M | 2.49M |
| 2020-04-01 | -1.85 | -1.59 | 2.84M | 2.08M |
| 2019-11-18 | -0.59 | -1.32 | 2.46M | 5.57M |
| 2019-08-28 | -1.38 | -1.34 | 3.65M | 3.43M |
| 2019-05-30 | -1.38 | -1.12 | 6.08M | 4.87M |
| 2019-04-03 | -0.85 | -1.12 | 12.56M | 8.00M |
| 2018-11-28 | -0.92 | -1.21 | 23.32K | 29.99K |
| 2018-08-29 | -0.64 | -1.05 | 20.89K | 29.15K |
| 2018-05-30 | -1.25 | -0.90 | 34.50K | 29.88K |
| 2018-03-28 | -1.13 | -0.99 | 328.53K | — |
| 2017-11-16 | -1.22 | -0.87 | 511.01K | 485.16K |
| 2017-08-18 | -1.10 | -0.85 | 505.97K | 362.34K |
| 2017-05-23 | -0.93 | -0.84 | 398.43K | 348.02K |
| 2017-03-22 | -0.55 | -0.61 | 1.09M | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Bodenhoff Mads | Buy | 3.00K | $110.00 | 330.00K |
| 2026-09-08 | Bodenhoff Mads | Sell | 3.00K | $110.00 | 330.00K |
| 2026-09-08 | Bodenhoff Mads | Sell | 3.00K | $270.19 | 810.57K |
| 2026-09-02 | HOLTUG LARS | Sell | 236 | $264.13 | 62.33K |
| 2026-08-14 | BIENAIME JEAN JACQUES | Buy | 900 | $246.91 | 222.22K |
| 2026-08-14 | BIENAIME JEAN JACQUES | Buy | 1.10K | $245.85 | 270.44K |
| 2026-06-02 | SMITH SCOTT THOMAS | Buy | 100 | $219.00 | 21.90K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 100 | $223.50 | 22.35K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 200 | $222.30 | 44.46K |
| 2026-05-29 | BIENAIME JEAN JACQUES | Buy | 200 | $223.76 | 44.75K |
| 2026-05-29 | SMITH SCOTT THOMAS | Buy | 250 | $223.32 | 55.83K |
| 2026-05-26 | BIENAIME JEAN JACQUES | Buy | 200 | $239.37 | 47.87K |
| 2026-05-26 | BIENAIME JEAN JACQUES | Buy | 200 | $236.24 | 47.25K |
| 2026-05-11 | JENSEN FLEMMING STEEN | Sell | 19.46K | $238.49 | 4.64M |
| 2026-04-14 | BIENAIME JEAN JACQUES | Buy | 9.16K | $249.84 | 2.29M |
| 2026-04-14 | BIENAIME JEAN JACQUES | Sell | 9.16K | $172.35 | 1.58M |
| 2026-03-23 | BIENAIME JEAN JACQUES | Other | 0 | — | — |
| 2026-03-23 | BIENAIME JEAN JACQUES | Other | 9.16K | $172.35 | 1.58M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 0 | — | — |
| 2026-03-18 | Fairey William | Other | 0 | — | — |
| 2026-03-18 | Fairey William | Other | 9.16K | $102.70 | 940.73K |
| 2026-03-18 | Fairey William | Other | 1.93K | — | — |
| 2026-03-18 | IMANI SIHAM | Other | 0 | — | — |
| 2026-03-18 | IMANI SIHAM | Other | 9.16K | $102.70 | 940.73K |
| 2026-03-18 | IMANI SIHAM | Other | 1.93K | — | — |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 0 | — | — |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 45.00K | $37.18 | 1.67M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | SMITH SCOTT THOMAS | Other | 9.55K | — | — |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 30.00K | $62.17 | 1.87M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | JENSEN MICHAEL WOLFF | Other | 9.55K | — | — |
| 2026-03-18 | Bodenhoff Mads | Other | 30.00K | $124.52 | 3.74M |
| 2026-03-18 | Bodenhoff Mads | Other | 3.12K | $139.65 | 435.29K |
| 2026-03-18 | Bodenhoff Mads | Other | 3.69K | $110.00 | 405.57K |
| 2026-03-18 | Bodenhoff Mads | Other | 2.77K | — | — |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 0 | — | — |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 20.00K | $37.18 | 743.60K |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | Other | 9.55K | — | — |
| 2026-03-18 | Morrison Lisa | Other | 0 | — | — |
| 2026-03-18 | Morrison Lisa | Other | 5.11K | $22.76 | 116.19K |
| 2026-03-18 | Morrison Lisa | Other | 5.00K | $37.18 | 185.90K |
| 2026-03-18 | Morrison Lisa | Other | 13.00K | $62.17 | 808.21K |
| 2026-03-18 | Morrison Lisa | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | Morrison Lisa | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | Morrison Lisa | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | Morrison Lisa | Other | 1.93K | — | — |
| 2026-03-18 | HOLTUG LARS | Other | 0 | — | — |
| 2026-03-18 | HOLTUG LARS | Other | 35.00K | $61.00 | 2.13M |
| 2026-03-18 | HOLTUG LARS | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | HOLTUG LARS | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | HOLTUG LARS | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | HOLTUG LARS | Other | 1.93K | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 0 | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 0 | — | — |
| 2026-03-18 | SPROGOE KENNETT | Other | 5.31K | $37.18 | 197.54K |
| 2026-03-18 | SPROGOE KENNETT | Other | 45.00K | $62.17 | 2.80M |
| 2026-03-18 | SPROGOE KENNETT | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | SPROGOE KENNETT | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | SPROGOE KENNETT | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | SPROGOE KENNETT | Other | 9.55K | — | — |
| 2026-03-18 | Wu Jay Donovan | Other | 0 | — | — |
| 2026-03-18 | Wu Jay Donovan | Other | 45.08K | $131.57 | 5.93M |
| 2026-03-18 | Wu Jay Donovan | Other | 9.55K | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 0 | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 0 | — | — |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 200.00K | $37.18 | 7.44M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 200.00K | $62.17 | 12.43M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 120.00K | $108.00 | 12.96M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 101.14K | $176.28 | 17.83M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 69.47K | $139.65 | 9.70M |
| 2026-03-18 | MIKKELSEN JAN MOLLER | Other | 28.95K | — | — |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 0 | — | — |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 20.00K | $62.17 | 1.24M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 27.00K | $108.00 | 2.92M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 22.75K | $176.28 | 4.01M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 14.50K | $139.65 | 2.03M |
| 2026-03-18 | JENSEN FLEMMING STEEN | Other | 9.55K | — | — |
| 2026-03-18 | Cha Albert | Other | 0 | — | — |
| 2026-03-18 | Cha Albert | Other | 542 | $62.17 | 33.70K |
| 2026-03-18 | Cha Albert | Other | 7.50K | $108.00 | 810.00K |
| 2026-03-18 | Cha Albert | Other | 6.42K | $176.28 | 1.13M |
| 2026-03-18 | Cha Albert | Other | 3.05K | $139.65 | 426.35K |
| 2026-03-18 | Cha Albert | Other | 1.93K | — | — |
| 2026-03-18 | Shu Aimee | Other | 0 | — | — |
| 2026-03-18 | Shu Aimee | Other | 9.55K | — | — |
| 2008-12-18 | Trinad Capital Master Fund Ltd. | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-18 | Wolf Jay | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-18 | ELLIN ROBERT S | Buy | 1.06M | $797,876.00 | 848.81B |
| 2008-12-02 | SCHWARTZ JEFFREY A | Buy | 1.80M | $1.25 | 2.25M |
| 2008-12-02 | SCHWARTZ JEFFREY A | Other | 0 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 334, holders +43 vs prior quarter. Ownership 104.00%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.28M | 0 | 0.00% | 2.74B |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.75M | 6.75M | New | 1.80B |
| AVORO CAPITAL ADVISORS LLC | 5.11M | 48.61K | +0.96% | 1.36B |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.80M | -15.17K | -0.32% | 1.28B |
| JUPITER TOPCO LLC | 3.65M | 3.65M | New | 973.38M |
| FMR LLC | 3.55M | -331.03K | -8.54% | 945.68M |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.63M | -596.16K | -18.46% | 702.55M |
| BLACKROCK, INC. | 2.21M | 1.55M | +234.59% | 589.94M |
| CAPITAL INTERNATIONAL INVESTORS | 1.99M | 29.77K | +1.52% | 530.40M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.88M | 14.63K | +0.79% | 500.14M |
| FRANKLIN TEMPLETON INC | 1.86M | -189.44K | -9.23% | 496.77M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.55M | -209.00K | -11.89% | 413.05M |
| AMERICAN CENTURY COMPANIES INC | 1.40M | 3.46K | +0.25% | 373.56M |
| PERCEPTIVE ADVISORS LLC | 1.16M | -367.70K | -24.01% | 310.39M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.12M | 1.12M | New | 299.40M |
| CAPITAL WORLD INVESTORS | 906.08K | 5.56K | +0.62% | 241.67M |
| PRINCIPAL FINANCIAL GROUP INC | 873.50K | -22.89K | -2.55% | 232.98M |
| POLAR CAPITAL HOLDINGS PLC | 616.91K | -34.80K | -5.34% | 164.54M |
| GOLDMAN SACHS GROUP INC | 559.53K | -6.66K | -1.18% | 149.24M |
| MORGAN STANLEY | 544.39K | -61.95K | -10.22% | 145.20M |
| STATE STREET CORP | 513.97K | 426.63K | +488.51% | 137.09M |
| INVESCO LTD. | 414.20K | 52.09K | +14.38% | 110.47M |
| GEODE CAPITAL MANAGEMENT, LLC | 403.15K | 330.21K | +452.71% | 107.53M |
| UBS GROUP AG | 401.88K | 194.54K | +93.83% | 107.19M |
| ALLIANCEBERNSTEIN L.P. | 399.29K | 121.09K | +43.53% | 106.50M |
Ascendis Pharma A/S (ASND) trades at $252.43, with a market cap of $16.61B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$16.61B
Market Cap
—
P/E
—
Forward P/E
—
Score